| Literature DB >> 29750144 |
Vivek Dhawan1, Jennifer Bown1, Angela Lau1, Deanne Langlois-Klassen1, Dennis Kunimoto1, Ravi Bhargava2, Linda Chui3,4,5, Simon M Collin6, Richard Long1.
Abstract
The epidemiology of tuberculosis (TB) in high-income countries is increasingly dictated by immigration. The influence of this trend on paediatric TB and TB elimination are not well defined. We undertook a 25-year conventional and molecular epidemiologic study of paediatric TB in Alberta, one of four major immigrant-receiving provinces in Canada. All isolates of Mycobacterium tuberculosis were DNA fingerprinted using standard methodology. Between 1990 and 2014, 176 children aged 0-14 years were diagnosed with TB. Foreign-born children or Canadian-born children of foreign-born parents accounted for an increasingly large proportion of total cases during the study period (from 32.1% to 89.5%). Of the 78 culture-positive cases, 35 (44.9%) had a putative source case identified by conventional epidemiology, with 34 (97.1%) having a concordant molecular profile. Of the remaining 43 culture-positive cases, molecular profiling identified spatially and temporally related sources in six cases (14.0%). These six children, along with four other children whose source cases were discovered through reverse-contact tracing, had a high morbidity and mortality. The increasing burden of paediatric TB in both foreign-born children and Canadian-born children of foreign-born parents calls for more timely diagnosis of source cases and more targeted screening for latent TB infection.Entities:
Year: 2018 PMID: 29750144 PMCID: PMC5938491 DOI: 10.1183/23120541.00131-2017
Source DB: PubMed Journal: ERJ Open Res ISSN: 2312-0541
The incidence of paediatric tuberculosis (TB) in Alberta by population group and age, 1990–2014
| Overall | 176 (100) | 159.37 | 1.10 | 1.20 (1.01–1.20) | |
| CBO | 61 (36) | 143.85 | 0.42 | 0.54 (0.39–0.66) | 1.00 |
| RFN | 56 (34) | 7.50 | 7.46 | 8.34 (6.13–11.07) | 16.37 (10.91–24.48) |
| FB | 59 (30) | 8.01 | 7.36 | 9.29 (6.43–12.95) | 18.25 (11.59–28.30) |
| Overall | 78 (100) | 5.31 | 1.47 | 1.47 (1.16–1.83) | |
| CBO | 39 (50) | 4.95 | 0.79 | 0.79 (0.56–1.08) | 1.00 |
| RFN | 23 (29) | 0.22 | 10.48 | 10.48 (6.64–15.72) | 13.31 (7.59–22.85) |
| FB | 16 (21) | 0.13 | 12.22 | 12.22 (6.99–19.85) | 15.53 (8.10–28.44) |
| Overall | 98 (100) | 10.63 | 0.92 | 0.92 (0.75–1.12) | |
| CBO | 22 (22) | 9.43 | 0.23 | 0.23 (0.15–0.35) | 1.00 |
| RFN | 33 (34) | 0.53 | 6.21 | 6.22 (4.29–8.75) | 26.70 (15.10–48.10) |
| FB | 43 (44) | 0.67 | 6.41 | 6.41 (4.64–8.64) | 27.50 (16.09–48.28) |
RRadj: age-sex adjusted incidence rate ratio; CBO: Canadian-born “other”; RFN: registered First Nations; FB: foreign born. #: based upon Canadian censuses conducted in 1986, 1991, 1996, 2001, 2006 and 2011, as well as registered First Nations population estimates provided by Indian and Northern Affairs Canada; ¶: adjusted rates by population group were standardised by age and sex, while adjusted rates by age and population group were standardised by sex.
FIGURE 1Age- and sex-adjusted incidence of paediatric tuberculosis (TB) by population group and time period in Alberta, 1990–2014. Population figures are from Statistics Canada. CBO: Canadian-born “other”; RFN: registered First Nations; FB: foreign born.
FIGURE 2Paediatric tuberculosis (TB) cases by 5-year period and population group in Alberta, 1990–2014. CBO-CB: Canadian-born “other” with Canadian-born parents; CBO-FB: Canadian-born “other” with one or more foreign-born parents; RFN: registered First Nations; FB: foreign born.
Demographic and clinical characteristics of paediatric tuberculosis (TB) cases by population group in Alberta, 1990–2014
| 56 | 18 | 43 | 59 | 176 | ||
| 0.001 | ||||||
| <5 | 23 (41) | 10 (56) | 29 (67) | 16 (27) | 78 (44) | |
| 5–14 | 33 (59) | 8 (44) | 14 (33) | 43 (73) | 98 (56) | |
| 0.09 | ||||||
| Female | 25 (45) | 10 (56) | 30 (70) | 35 (59) | 100 (57) | |
| Male | 31 (55) | 8 (44) | 13 (30) | 24 (41) | 76 (43) | |
| 0.03 | ||||||
| Pulmonary | 51 (91) | 14 (78) | 36 (84) | 41 (70) | 142 (81) | |
| Extrapulmonary¶ | 5 (9) | 4 (22) | 7 (16) | 18 (31) | 34 (19) | |
| <0.001 | ||||||
| Contact tracing | 52 (93) | 14 (78) | 27 (63) | 15 (25) | 108 (61) | |
| Symptoms | 4 (7) | 4 (22) | 14 (33) | 37 (63) | 59 (34) | |
| Other screening+ | 0 (0) | 0 (0) | 2 (5) | 7 (12) | 9 (5) | |
| 0.47 | ||||||
| Positive | 22 (39) | 6 (33) | 16 (37) | 34 (58) | 78 (44) | |
| Negative | 32 (57) | 9 (50) | 24 (56) | 25 (42) | 90 (51) | |
| Unknown§ | 2 (4) | 3 (17) | 3 (7) | 0 (0) | 8 (5) | |
Data are presented as n or n (%), unless otherwise stated. CBO-CB: Canadian-born “other” with Canadian-born parents; CBO-FB: Canadian-born “other” with foreign-born parents; RFN: registered First Nations; FB: foreign born. #: Pearson's Chi-squared test or Fisher's exact test if cells contain values <5; ¶: Extrapulmonary includes all cases with an International Classification of Diseases Ninth Revision (ICD-9) code of 013 (TB of meninges and the central nervous system) and/or 018 (miliary TB) with or without disease in other sites. It also includes the single ICD-9 codes 014 (TB of the intestines, peritoneum and mesenteric glands), 015 (TB of the bones and joints), 016 (TB of the genito-urinary system) and 017 (TB of other organs); +: other screening includes immigration medical evaluations, international adoptee screening and incidental findings; §: unknown means that no diagnostic specimens were submitted.
Culture status of paediatric tuberculosis (TB) cases in Alberta by demographic and clinical characteristics, 1990–2014
| 168 | 90 (54) | 78 (46) | |||
| 0.01 | |||||
| <5 | 71 | 46 (65) | 25 (35) | 1 | |
| 5–14 | 97 | 44 (45) | 53 (55) | 2.21 (1.16–4.21) | |
| 0.23 | |||||
| Female | 93 | 46 (50) | 47 (51) | 1 | |
| Male | 75 | 44 (59) | 31 (41) | 0.69 (0.37–1.27) | |
| 0.20 | |||||
| CBO-CB | 15 | 9 (60) | 6 (40) | 1 | |
| CBO-FB | 40 | 24 (60) | 16 (40) | 1.00(0.30–3.36) | |
| RFN | 54 | 32 (59) | 22 (41) | 0.97(0.30–3.11) | |
| FB | 59 | 25(42) | 34(58) | 0.49(0.15–1.56) | |
| 0.02 | |||||
| Pulmonary | 136 | 79 (58) | 57 (42) | 1 | |
| Extrapulmonary | 32 | 11 (34) | 21 (66) | 0.38 (0.17–0.85) | |
| <0.001 | |||||
| Symptoms | 58 | 19 (33) | 39 (67) | 1 | |
| Contact tracing¶ | 101 | 69 (68) | 32 (32) | 0.22 (0.11–0.45) | |
| Other screening+ | 9 | 2 (22) | 7 (78) | 1.71 (0.32–9.01) | |
Data are presented as n or n (%), unless otherwise stated. CBO-CB: Canadian-born “other” with Canadian-born parents; CBO-FB: Canadian-born “other” with foreign-born parents; RFN: registered First Nations; FB: foreign born; OR: odds ratio (crude and unadjusted for any other variables in the table). #: Pearson's Chi-squared test or Fisher's exact test if cells contain values <5. ¶: of the 101 children whose method of detection was contact tracing and who had one or more specimens submitted for culture, 85 had primary pulmonary TB complex alone (see figure 3). Of these only 22 (25.9%) were culture-positive. +: other screening includes immigration medical evaluations, international adoptee screening and incidental findings.
FIGURE 3Paediatric tuberculosis (TB) in Alberta by method of detection and strategically placed TB elimination activities. The dotted lines highlight contacts with a single International Classification of Diseases Ninth Revision (ICD-9) code of 010.0 (primary tuberculous complex). Of the CBO-FB children without a source case in Alberta (n=9), five could, on the basis of their travel history or their unique Mycobacterium tuberculosis DNA fingerprints, be reasonably said to have acquired their infection overseas. PTB: pulmonary TB; CBO-CB: Canadian-born “other” with Canadian-born parents; CBO-FB: Canadian-born “other” with one or more foreign-born parents; RFN: registered First Nations; FB: foreign born; ME: molecular epidemiology; CNS: central nervous system; LTBI: latent TB infection.
Utility of conventional epidemiology (CE) for the identification of paediatric tuberculosis (TB) source cases
| 176 | 111 (63) | 65 (37) | ||
| <5 | 78 | 54 (69) | 24 (31) | 1.0 |
| 5–14 | 98 | 57 (58) | 41 (42) | 1.62 (0.87–3.03) |
| Female | 100 | 59 (59) | 41 (41) | 1.0 |
| Male | 76 | 52 (68) | 24 (32) | 0.66 (0.35–1.24) |
| CBO | 61 | 43 (71) | 18 (30) | 1.0 |
| RFN | 56 | 53 (95) | 3 (5) | 0.14 (0.04–0.50) |
| FB | 59 | 15 (25) | 44 (75) | 7.01 (3.14–15.66) |
| Contact tracing | 108 | 107 (99) | 1 (1)# | |
| Symptoms | 59 | 4 (4)¶ | 55 (97) | |
| Other screening+ | 9 | 0 (0) | 9 (100) | |
Data is presented as n or n (%), unless otherwise stated. CBO: Canadian-born “other”; RFN: registered First Nations; FB: foreign born; OR: odds ratio. #: this child was a close contact of a relative who lived in a neighbouring province-there was no source case in Alberta; ¶: four children were index cases with symptoms and their source cases were identified through reverse contact tracing; +: other screening includes immigration medical evaluations, international adoptee screening and incidental findings.
Utility of molecular epidemiology (ME) for the identification of paediatric tuberculosis (TB) source cases
| 78 | 35 | 34 (97) | 43 | 6 (14) | |
| <5 | 25 | 11 | 11 (100) | 14 | 4 (29) |
| 5–14 | 53 | 24 | 23 (96) | 29 | 2 (7) |
| Female | 47 | 20 | 19 (95) | 27 | 3 (11) |
| Male | 31 | 15 | 15 (100) | 16 | 3 (19) |
| CBO | 22 | 12 | 11 (92) | 10 | 4 (40) |
| RFN | 22 | 20 | 20 (100) | 2 | 1 (50) |
| FB | 34 | 3 | 3 (100) | 31 | 1 (3) |
| Symptoms | 39 | 4 | 4 (100) | 35 | 6 (17) |
| Contact tracing | 32 | 31 | 30 (97) | 1 | 0 (0) |
| Other screening+ | 7 | 0 | 0 (0) | 7 | 0 (0) |
Data are presented as n or n (%), unless otherwise stated. CE: conventional epidemiology; CBO: Canadian-born “other”; RFN: registered First Nations; FB: foreign born. #: total culture-positive cases; ¶: odds ratios of paediatric TB cases with source cases identified by ME only versus paediatric TB cases without source cases identified by ME or CE for various characteristics are as follows: age 5–14 years (0.1852 (95% CI 0.03–1.17)); male sex (1.8462 (95% CI 0.33–10.49)); FB population group (0.0467 (95% CI 0.005–0.47)); detection by symptoms (3.7458 (95% CI 0.19–73.45)). +: other screening includes immigration medical evaluations, international adoptee screening and incidental findings.